Top news of the week: 25.02.2020.
Medicine, Biotechnology, Pharmacology, Economics, New York City, Pneumococcal conjugate vaccine
Companies And Industries
A Chinese biotech partners with GSK to boost its coronavirus vaccine development by @DrewQJoseph https://t.co/ObFYZb6deU
OpenA Chinese biotech partners with GSK to boost its coronavirus vaccine development
A Chinese biotech has taken up vaccine maker GSK’s offer to share its vaccine-boosting platform as it works to develop a product that can stop infection from the novel coronavirus, the ...
Israeli biotech NeoTX lands $45M series C for combo I-O cancer trials https://t.co/KKu231oD7X https://t.co/nj3kBobPed
OpenIsraeli biotech NeoTX lands $45M series C for combo I-O cancer trials
NeoTX Therapeutics has nabbed a healthy $45 million third funding round as it looks to continue work on its early-stage cancer combo test and in-license new tech.
Bharat Biotech Plans Coronavirus Vaccine
<p>After two Indian vaccine makers, Serum Institute of India and Cadila Healthcare joined the fight against COVID-19, Bharat Biotech may follow suit. Others like Hilleman have decided ...
In raw numbers, 2019 saw fewer IPOs in healthcare than 2018 did. Despite that decline, the sector outraised itself, banking more in total proceeds than the year before. https://t.co/g93tqf9DOY
OpenTop 10 biotech IPOs in 2019
The big question at the start of 2019 was whether the IPO window would stay open for biotech companies, particularly those seeking to pull off ever-larger IPOs at increasingly earlier ...
The Dish’s Weekly Biotechnology News Wrap Up – February 21, 2020
*|RSSFEED:DATE|* Incase you missed it. We summarize the week's top biotechnology stories.
India ramps up efforts to move up biotech value chain
HYDERABAD, India – Multinationals and domestic companies are stepping up research in India, including working to leverage the country’s digital and entrepreneurial capabilities, to boost ...
STAT Health Tech Summit 2020
Breakthroughs in health and medicine are not just biological — they’re technological. Join us for our next STAT Summit as we assemble top executives, policymakers, and researchers working ...
Everest hires ex-Lilly leader to oversee push for Chinese market https://t.co/PkFpsqTRKw https://t.co/5xICnaCda5
OpenEverest hires ex-Lilly leader to oversee push for Chinese market
Everest Medicines has named Eli Lilly veteran Kerry Blanchard as its CEO. Blanchard takes up the top job at the Shanghai-based biopharma company on the back of a career built around a ...